Stay updated on Ruxolitinib for Eosinophilic Disorders Clinical Trial
Sign up to get notified when there's something new on the Ruxolitinib for Eosinophilic Disorders Clinical Trial page.

Latest updates to the Ruxolitinib for Eosinophilic Disorders Clinical Trial page
- Check5 days agoChange Detected- Revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check34 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check41 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3 on the page.SummaryDifference0.1%

- Check69 days agoChange DetectedRevision: v3.4.2 was added and the prior v3.4.1 notice removed, indicating an administrative update. No core content or study details were changed; to avoid alerts for minor updates, set an alert condition by clicking below.SummaryDifference0.4%

- Check76 days agoChange DetectedA site-wide government funding/status notice was added and the page shows Revision: v3.4.1, replacing the previous v3.4.0.SummaryDifference0.4%

- Check83 days agoChange DetectedThe page adds a glossary and new QC-related fields (Last Update Submitted that Met QC Criteria, Last Update Posted, Revision: v3.4.0) while removing older QC indicators and No FEAR Act data entries (Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, Revision: v3.3.4).SummaryDifference0.3%

Stay in the know with updates to Ruxolitinib for Eosinophilic Disorders Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ruxolitinib for Eosinophilic Disorders Clinical Trial page.